People In Brief
This article was originally published in The Rose Sheet
You may also be interested in...
E.l.f. Charms Shoppers With Value Products Modeled On Top Makeup Brands
The e.l.f. business model is paying off in the recession, with a growing number of consumers embracing the company's principle that "every woman should have the opportunity to experience luxury cosmetics without sacrificing her budget.
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.